<?xml version="1.0" encoding="UTF-8"?>
<p>Current applications: remdesivir (RDV) is one of the most important drugs named in the treatment of COVID-19 and is being extensively researched. In 2017, Gilead Sciences developed RDV for the treatment of Ebola virus infection. It is a broad-spectrum drug having antiviral activities against RNA viruses such as SARS-CoV-2, SARS-CoV, and MERS-CoV [
 <xref rid="REF12" ref-type="bibr">12</xref>].
</p>
